Latest news
Minerva Neurosciences (NASDAQ: NERV) logs $107.9M loss but holds $75.4M cash - Stock TitanStock Titan · Fri, 07 Aug 2026 11:31:14 GMTMinerva Neurosciences (Nasdaq: NERV) swings to Q2 profit on warrant gain - Stock TitanStock Titan · Fri, 07 Aug 2026 11:14:09 GMTMinerva's schizophrenia trial is designed to enroll 380 patients - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTMinerva Neurosciences (NERV) awards options tied to Phase 3 trial - Stock TitanStock Titan · Mon, 03 Aug 2026 22:05:46 GMTEnergizer Holdings (ENR) group reports 120,000-share buy - Stock TitanStock Titan · Mon, 27 Jul 2026 21:15:45 GMT